Target intelligence / Profile preview

Multiple soluble plasma proteins

Molecular classification
Other
01

Overview

Multiple soluble plasma proteins is a collective term referring to the heterogeneous mixture of proteins found in human plasma, including albumin, globulins, and fibrinogen. These proteins perform vital physiological roles such as maintaining colloid osmotic pressure, transporting lipids and hormones, and facilitating the immune response and blood coagulation [StatPearls, NBK542197]. In a pharmacological context, this term is typically used to describe the target of plasma-derived products or drugs that exhibit broad, non-specific binding across various blood proteins [DrugBank, DB00062]. Because it encompasses hundreds of distinct molecular entities with diverse functions, it is considered an imprecise designation for a specific therapeutic target in modern drug discovery, which favors well-defined molecular structures [NCBI, NBK22592]. Clinically, therapies involving these proteins are often used for volume expansion or as replacement therapy in conditions like hypovolemia, cirrhosis, or primary immunodeficiency [PubMed, 28633674].

Other names
Plasma proteinsSerum proteinsBlood proteinsCirculating proteins
02

Mechanism of action

The mechanism of action involves the replacement of deficient proteins to restore physiological function, the expansion of plasma volume to maintain hemodynamics, or the non-specific binding and neutralization of circulating pathogens and toxins [DrugBank, DB00062; StatPearls, NBK542197].

03

Biological functions

TransportOsmotic pressure regulationImmune responseBlood coagulationBuffering
04

Disease associations

HypovolemiaImmunodeficiencyCoagulopathyLiver diseaseInflammation
05

Safety considerations

Volume overloadAnaphylactic reactionsTransmission of blood-borne pathogensTransfusion-related acute lung injury (TRALI)
06

Interacting drugs

Albumin human

4 more in the full profile.

07

Biomarkers

Total proteinSerum albuminProthrombin time (PT)International Normalized Ratio (INR)Immunoglobulin G (IgG) levels

Beyond the preview

Go deeper on Multiple soluble plasma proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple soluble plasma proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call